Conformis inc (CFMS)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flows from operating activities:
Net loss

-9,353

-5,433

-8,701

-6,763

-7,581

-9,870

-7,437

-14,057

-12,001

-11,858

-12,472

-12,090

-17,160

-15,740

-12,762

-14,052

-15,034

-14,990

-17,107

-10,892

-14,257

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization expense

1,077

1,045

1,056

1,071

1,065

1,107

1,062

1,005

948

971

950

905

843

819

791

809

734

728

692

651

548

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

4

0

2

1

0

114

12

9

Stock-based compensation expense

766

658

73

958

1,148

1,142

960

911

873

1,899

1,408

1,449

1,292

1,834

1,359

1,187

944

1,013

748

758

1,088

Unrealized foreign exchange loss

-675

900

-1,277

410

-639

-556

-165

-2,079

994

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

288

283

279

274

310

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for bad debts on trade receivables

23

48

77

-19

0

-56

6

-2

-20

-20

9

-33

29

-55

53

190

0

188

7

122

42

Non-cash interest expense

175

198

8

191

26

43

27

28

27

27

27

32

14

0

0

0

0

-

-

-

-

Amortization/accretion on investments

0

0

0

0

4

35

34

-18

-33

-43

-42

-42

-75

-86

-101

-128

0

-

-

-

-

Deferred tax

-

-

-

-

-

-36

16

0

-17

-5

42

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-2,881

638

-695

-1,761

-252

1,524

-345

124

-1,331

581

740

-1,217

-1,594

781

814

-267

-1,332

6,794

-2,762

1,361

714

Royalty receivable

-15

-5

2

20

3

-10,489

10,434

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

-216

516

919

1,077

27

-525

999

881

-1,005

-1,392

-1,207

401

-337

-35

-222

58

399

855

1,286

340

1,348

Prepaid expenses and other assets

-952

1,369

-70

255

69

-113

-209

-192

-15

-266

-98

-312

-1,094

1,762

417

-74

-555

76

721

-1,309

1,557

Accounts payable, accrued expenses and other liabilities

-1,883

639

1,540

-894

330

-866

-2,233

1,252

802

-38

-665

-1,380

677

3,329

1,577

-4,163

694

-273

-1,700

1,361

2,581

Advance on research and development

-310

-

-

-

-324

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-77

-76

-

-76

-77

-76

-77

-75

5,084

0

Other long-term liabilities

-

-

-

-

-

-

-

-

-2

-1

201

290

-3

-2

-1

-33

-20

-20

-6

24

-49

Net cash used in operating activities

-4,478

-4,339

9,513

-3,774

-4,238

2,079

-9,676

-9,579

-8,000

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-9,734

-11,284

-12,292

-9,839

-15,732

-11,269

-20,951

-12,081

-7,761

-13,657

Cash flows from investing activities:
Acquisition of property and equipment

1,477

824

804

541

757

1,113

604

1,042

1,300

1,119

1,082

1,576

1,456

872

2,101

890

3,298

977

689

1,562

1,415

(Increase) decrease in restricted cash

-

-

-

-

-

-

-

-

-

0

-300

0

462

0

0

-300

0

-120

-3,608

-53

-56

Purchase of short term investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26,939

-

-

-

0

Purchase of investments

-

-

-

-

-

7,981

5,253

10,952

3,244

7,989

2,515

6,917

13,570

-

-

-

-

-

-

-

-

Maturity of investments

0

0

0

0

7,250

16,020

7,500

12,700

10,895

9,000

6,500

7,000

9,625

20,550

11,000

5,500

0

-

-

-

-

Net cash (used in) provided by investing activities

-1,477

-824

-804

-541

6,493

6,926

1,643

706

6,351

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided/(used) in investing activities

-

-

-

-

-

-

-

-

-

-

-

-1,493

-5,863

11,623

6,703

-23,514

-30,237

-857

2,919

-1,509

-1,359

Cash flows from financing activities:
Proceeds from exercise of common stock options

-

-

-

-

-

-

-

-

-

6

87

82

1,933

1,874

552

836

825

245

172

263

126

Debt issuance costs

-

-

-

-

-

-

-

-

-

0

0

137

297

0

0

0

0

-

-

-

-

Proceeds from issuance of debt

-

-

-

-

-

-

-

-

-

0

0

15,000

15,000

0

0

0

0

-

-

-

-

Payments on long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

261

77

75

72

71

10,070

69

68

Net proceeds from issuance of common stock

1,141

1,999

0

3,000

0

944

500

0

21,324

0

0

1,023

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,141

2,062

114

6,351

0

-14,281

500

112

21,324

-

-

-

-

-

-

-

-

-

-

-

-

Foreign exchange effect on cash and cash equivalents

-62

62

-49

7

-19

-29

96

-195

55

-

-

-

-

-

-

-

-

-

-

-

-

(Decrease) increase in cash, cash equivalents and restricted cash

-4,876

-3,039

8,774

2,043

2,236

-5,305

-7,437

-8,956

19,730

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

15,968

16,636

1,613

475

761

753

-31

133,928

610

58

Foreign exchange effect on cash and cash equivalents

-

-

-

-

-

-

-

-

-

-423

-1,006

-1,926

-354

1,327

-166

-285

151

-178

-60

217

-3

Decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-8,199

-12,660

2,815

-865

2,271

-2,827

-38,770

-40,602

-22,017

124,706

-8,443

-14,961

Supplemental information:
Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

-

-

-

29

Cash paid for interest

346

351

347

1,094

331

950

653

636

598

589

492

61

307

-

-

-

8

-

-

-

242

Noncash Investing and Financing Items [Abstract]
Operating leases right-of-use assets obtained in exchange for lease obligations

0

-

0

0

6,988

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-